Patent Assignment
Reel/Frame 075320/0707
Change of Name
Recorded: 2026-04-01
Pages: 24
Assignor
MITSUBISHI TANABE PHARMA CORPORATION
Executed: 2025-12-01
Assignee
TANABE PHARMA CORPORATION
3-2-10, DOSHO-MACHI, CHUO-KU, OSAKA-SHI, 5418505, JAPAN
Covered Property
(1)
Soluble Pharmaceutical Compositions Comprising Salts of Disubstituted 1, 2, 4-Triazine Compound
Application:
18/580,999 →
Publication:
US 2024/0366616
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 22, 2024
From: MCKEAN, ROBERT; THIBERT, ROCH; VADAS, ELIZABETH
To: MINERALYS THERAPEUTICS, INC.
Reel/Frame 066196/0046 →
Assignment of Assignor's Interest
Jan 24, 2024
From: OHASHI, YOSHINORI; OZAKI, FUMINORI; OHSHIMA, HIROKI; NAGATA, HIROOMI
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 066233/0666 →
Patent Security Agreement
Jun 3, 2026
From: MINERALYS THERAPEUTICS, INC.
To: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
Reel/Frame 075769/0102 →